Clarus Lifesciences II, L.P. → CATABASIS PHARMACEUTICALS INC

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on CATABASIS PHARMACEUTICALS INC

Filed	Form	Filer	Stake	Shares
2026-01-28	SCHEDULE	Magnetar Financial LLC	—	—	view →
2021-09-23	SC	Viridian, LLC	—	—	view →
2021-06-25	SC	Xontogeny, LLC	—	—	view →
2021-06-25	SC	PERCEPTIVE ADVISORS LLC	—	—	view →
2018-02-09	SC	Clarus Lifesciences II, L.P.	—	—	view →

Other Filings by Clarus Lifesciences II, L.P.

Filed	Form	Issuer	Stake	Shares
2019-06-12	SC	NanoString Technologies Inc	—	—	view →
2019-03-22	SC	NanoString Technologies Inc	—	—	view →
2019-01-11	SC	NanoString Technologies Inc	—	—	view →
2018-02-09	SC	CATABASIS PHARMACEUTICALS INC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →